Connect with us

Covid

Bharat Biotech in Phase 3 data: Covaxin overall 77.8% effective

Published

on

Bharat Biotech in Phase 3 data: Covaxin overall 77.8% effective

In a statement, Bharat Biotech claimed that the Covaxin is overall 77.8 per cent effective against Covid, citing the data from the third phase of clinical trials.

However, the data is yet to be peer-reviewed.

The vaccine maker said that it was also found to be “93.4 per cent effective” against severe symptomatic Covid-19.
“We are proud to put India on the global map with scientific conviction, competence and commitment. Covaxin scores 10 world-class publications endorsing Innovation, clinical research, data, safety, efficacy. Thank collaborators & Positive BB teamwork enduring a pandemic (sic),” Bharat Biotech co-founder Suchitra Ella said in a late-night tweet.

In a statement, the vaccine maker further said, “Efficacy analysis demonstrates Covaxin to be 77.8 per cent effective against symptomatic COVID-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group.”

“The safety profile of Covaxin is now well established based on inactivated vaccines technology, and in large part due to the extensive 20-year safety track record of Bharat Biotech’s vero cell manufacturing platform. Furthermore, Bharat Biotech has so far not sought indemnity for Covaxin from the governments,” it said.

Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech, said, “The successful safety and efficacy readouts of Covaxin as a result of conducting the largest ever Covid vaccines trials in India establishes the ability of India and developing world countries to focus towards innovation and novel product development. We are proud to state that Innovation from India will now be available to protect global population.”

“The successful development of Covaxin has consolidated the position of Indian academia and Industry in the global arena,” Prof. (Dr) Balram Bhargava, Secretary Department of Health Research & Director General Indian Council of Medical Research, said.

Covid

Study: 4th Covid vaccine dose effective in protecting people over 60

Published

on

By

Study: 4th Covid vaccine dose effective in protecting people over 60

As per the new Israeli-led study, the largest healthcare organisation Clalit said fourth dose of Covid vaccine is effective for protecting people aged 60 and above.

The study found that a fourth dose can reduce the possibilities of symptomatic infection, hospitalisation, serious illness and mortality among the elders, Clalit said, Xinhua news agency reported.

In the study, published in the New England Journal of Medicine, Clalit researchers and their colleagues from Harvard University in Boston analysed data from 182,122 Clalit members, all aged 60 and above, who received Pfizer’s fourth dose.

“The study unequivocally demonstrates that the fourth dose provides effective protection in preventing morbidity,” said Ran Balicer, Director of the Clalit Research Institute.

“It will help every person to make a decision on the fourth vaccine based on their level of personal risk,” he added.

Continue Reading

Covid

Covid-19: Here are the symptoms of fourth wave

Published

on

By

Covid-19: Here are the symptoms of fourth wave

covid-19 pandemic. BA.2 has two characteristics Рthey are dizziness and extreme tiredness. BA.2 sub-variant or stealth omicron affects more on the stomach and intestines of the people, which leads to digestive problems. there is currently no evidence that people can catch covid-19 from food. the virus that causes covid-19 can be killed at temperatures  similar to that of other known viruses and bacteria found in food.

Symptoms of Omicron:

  1. Fever
  2. Continuous Cough
  3. Fatigue
  4. Muscle and body health
  5. Shortness of breath
  6. Difficulty in breathing
  7. Skin rash
  8. Sleeping paralysis
  9. Heartburn
  10. Bloating
  11. Back pain
  12. Delirium
  13. A loss of appetite
  14. High temperature
  15. Sore throat
  16. Chest pain
  17. Abdominal pain
  18. Covid toes or figures
  19. Covid tongue
  20. Night sweats
  21. Diarrhoea
  22. Hoarse voice
  23. New loss of taste and smell
  24. Congestion or running nose
  25. Nausea or vomiting
  26. Headache
Continue Reading

Covid

Covid-19: WHO shares post COVID symptoms

Published

on

By

Covid-19: WHO shares post COVID symptoms

In the third year of pandemic, it is not just a fight against COVID, we have another challenge ahead of us i.e. dealing with post-COVID conditions. They are also known as long COVID conditions. With the growing number of cases of long COVID it is confirmed that COVID does not spare any body organ and it affects the biological ecosystem. Fatigue, trouble in breathing and cognitive dysfunction is the most common symptoms.

Fatigue: It is very common response from the body when fighting against any viral infection. It may last for weeks and it is very common symptom seen in all the patients who recovered from COVID.

Trouble in breathing: Even with the minimal physical activity person may have trouble in breathing. It is very common occurrence in the people who have been infected with COVID.

Cognitive dysfunction: It is commonly referred as brain fog. It actually means people having trouble with their attention, trouble in concentrating, trouble in recall or memory, trouble in sleeping.

Continue Reading

Trending